Header Logo

Zoe Arvanitakis

Concepts (234)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Alzheimer Disease
28
2025
800
3.870
Why?
Cognition Disorders
19
2020
437
3.020
Why?
Brain
23
2025
707
2.950
Why?
Dementia
13
2019
236
2.410
Why?
Cognitive Dysfunction
8
2025
449
2.100
Why?
Cognition
14
2025
641
1.900
Why?
Diabetes Mellitus, Type 2
6
2020
82
1.860
Why?
Diabetes Mellitus
3
2023
40
1.680
Why?
Antibodies, Antiphospholipid
3
2019
19
1.380
Why?
Humans
60
2025
12240
1.370
Why?
Aged
40
2025
4000
1.360
Why?
Neuropsychological Tests
24
2025
558
1.300
Why?
Aged, 80 and over
34
2025
2152
1.290
Why?
Cardiovascular Diseases
4
2025
166
1.260
Why?
Aging
14
2020
680
1.220
Why?
Brain Infarction
5
2021
36
1.200
Why?
Female
45
2025
6974
1.110
Why?
Biomarkers
5
2025
294
1.010
Why?
Male
43
2025
6815
1.010
Why?
Memory Disorders
4
2020
68
0.980
Why?
Insulin
3
2023
41
0.920
Why?
Cerebral Infarction
4
2023
63
0.910
Why?
Insulin Resistance
2
2023
19
0.910
Why?
Neurofibrillary Tangles
4
2018
64
0.890
Why?
Plaque, Amyloid
3
2018
45
0.830
Why?
Metformin
1
2023
9
0.800
Why?
Insulin-Like Growth Factor I
1
2024
36
0.790
Why?
Neuroimaging
4
2021
66
0.780
Why?
Memory, Episodic
1
2023
43
0.780
Why?
Cerebral Amyloid Angiopathy
6
2021
57
0.760
Why?
tau Proteins
6
2021
88
0.760
Why?
Cell-Free Nucleic Acids
1
2023
9
0.750
Why?
Blood Pressure
3
2019
99
0.730
Why?
Neuropathology
2
2019
42
0.680
Why?
Risk Factors
13
2024
1049
0.660
Why?
Longitudinal Studies
16
2020
651
0.650
Why?
Cohort Studies
11
2019
827
0.620
Why?
Adipokines
1
2019
5
0.600
Why?
Cerebral Arteries
3
2016
18
0.600
Why?
Motor Disorders
1
2019
13
0.580
Why?
Insulin-Like Growth Factor Binding Protein 5
1
2019
20
0.580
Why?
Depressive Disorder
1
2019
90
0.550
Why?
Apolipoprotein E4
5
2025
106
0.550
Why?
Cerebrovascular Disorders
2
2018
60
0.550
Why?
Signal Transduction
1
2019
246
0.540
Why?
Follow-Up Studies
7
2019
726
0.530
Why?
Hypertension
1
2018
85
0.530
Why?
Parkinsonian Disorders
3
2007
91
0.510
Why?
Intracranial Arteriosclerosis
3
2021
29
0.390
Why?
Epidemiologic Research Design
1
2012
12
0.370
Why?
Movement Disorders
1
2012
32
0.370
Why?
Cross-Sectional Studies
3
2024
400
0.360
Why?
Diabetes Complications
2
2016
28
0.330
Why?
Neurodegenerative Diseases
2
2001
60
0.320
Why?
Amyloid beta-Peptides
2
2018
98
0.310
Why?
Prospective Studies
5
2018
817
0.300
Why?
Heme Oxygenase-1
2
2009
3
0.300
Why?
Middle Aged
9
2024
4043
0.280
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
46
0.270
Why?
Asparagine
1
2006
2
0.250
Why?
Lysine
1
2006
3
0.250
Why?
Independent Living
2
2018
137
0.250
Why?
Hospitalization
2
2018
158
0.240
Why?
Vascular Endothelial Growth Factor A
2
2024
41
0.240
Why?
Neuroglia
2
2007
19
0.240
Why?
Cholesterol
2
2025
30
0.230
Why?
Mutation
1
2006
175
0.230
Why?
Exercise
2
2025
233
0.220
Why?
Gene Expression Regulation, Enzymologic
1
2005
19
0.220
Why?
Postmortem Changes
3
2019
17
0.220
Why?
ATP Binding Cassette Transporter 1
1
2025
3
0.220
Why?
Cellular Senescence
1
2025
13
0.220
Why?
Lysosomes
1
2025
13
0.220
Why?
Autopsy
5
2021
174
0.220
Why?
Mental Status Schedule
3
2018
38
0.210
Why?
Body Mass Index
2
2020
221
0.210
Why?
Brain-Derived Neurotrophic Factor
1
2024
19
0.200
Why?
5-Methylcytosine
1
2023
2
0.190
Why?
Memory
2
2020
112
0.190
Why?
Creatinine
1
2002
29
0.180
Why?
Age Factors
3
2021
350
0.180
Why?
DNA Methylation
1
2023
93
0.180
Why?
Anniversaries and Special Events
1
2021
2
0.180
Why?
Neuromuscular Diseases
1
2001
2
0.170
Why?
Magnetic Resonance Imaging
4
2015
464
0.170
Why?
Incidence
3
2018
338
0.170
Why?
Amyloid beta-Protein Precursor
1
2021
7
0.170
Why?
Genetic Variation
2
2016
44
0.170
Why?
Vascular Diseases
1
2021
25
0.160
Why?
Inflammation
2
2022
124
0.150
Why?
Excitatory Amino Acid Antagonists
1
2019
9
0.150
Why?
Arteriolosclerosis
2
2018
25
0.150
Why?
Comorbidity
4
2014
209
0.150
Why?
Cholinesterase Inhibitors
1
2019
9
0.150
Why?
Memantine
1
2019
5
0.150
Why?
Leptin
1
2019
11
0.150
Why?
Blood Pressure Determination
1
2019
8
0.150
Why?
HSP27 Heat-Shock Proteins
1
2019
14
0.150
Why?
Frontal Lobe
1
1999
32
0.140
Why?
Temporal Lobe
1
1999
29
0.140
Why?
Proteomics
1
2019
39
0.140
Why?
Brain Diseases
1
1999
30
0.140
Why?
Prefrontal Cortex
1
2019
66
0.140
Why?
Central Nervous System Infections
1
1998
4
0.140
Why?
Economics
1
2018
8
0.140
Why?
Mycobacterium tuberculosis
1
1998
11
0.140
Why?
Tuberculosis
1
1998
12
0.140
Why?
Community Health Planning
1
2018
7
0.140
Why?
Sex Characteristics
1
2018
64
0.140
Why?
Depression
1
2020
229
0.130
Why?
White Matter
2
2016
52
0.130
Why?
Health Literacy
1
2018
45
0.130
Why?
Ambulatory Care
1
2017
36
0.130
Why?
Chronic Disease
1
2017
186
0.120
Why?
Arterioles
1
2016
9
0.120
Why?
Organ Specificity
1
2016
18
0.120
Why?
Cerebrovascular Circulation
1
2016
11
0.120
Why?
Neoplasms
1
2017
94
0.110
Why?
Microglia
1
2016
64
0.110
Why?
Linear Models
2
2016
115
0.110
Why?
Motor Skills
1
2015
32
0.110
Why?
beta 2-Glycoprotein I
1
2014
6
0.110
Why?
Phosphatidylserines
1
2014
6
0.110
Why?
Lupus Coagulation Inhibitor
1
2014
6
0.110
Why?
Autoantigens
1
2014
10
0.110
Why?
Single-Blind Method
1
2014
46
0.110
Why?
Lewy Bodies
2
2012
96
0.110
Why?
Cerebral Cortex
2
2006
77
0.100
Why?
Motor Activity
1
2015
175
0.100
Why?
Severity of Illness Index
2
2015
423
0.100
Why?
Immunohistochemistry
2
2021
171
0.090
Why?
Chicago
3
2020
453
0.090
Why?
Adult
4
2006
3557
0.090
Why?
Research Design
1
2012
79
0.090
Why?
Microcirculation
1
2011
15
0.080
Why?
Amyloid
1
2010
20
0.080
Why?
Atrophy
2
2001
29
0.080
Why?
Lewy Body Disease
2
2012
54
0.080
Why?
Reactive Oxygen Species
2
2022
55
0.070
Why?
Sterols
1
2009
2
0.070
Why?
Glial Fibrillary Acidic Protein
2
2007
30
0.070
Why?
Statistics as Topic
2
2006
51
0.070
Why?
Treatment Outcome
2
2025
1478
0.070
Why?
Risk Assessment
2
2006
295
0.070
Why?
Housing for the Elderly
1
2007
5
0.060
Why?
Receptors, Erythropoietin
1
2007
1
0.060
Why?
Chromosomes, Human, Pair 17
1
2006
1
0.060
Why?
Family Health
1
2006
18
0.060
Why?
Fluorodeoxyglucose F18
1
2006
18
0.060
Why?
Positron-Emission Tomography
1
2006
36
0.060
Why?
Decision Support Techniques
1
2006
24
0.060
Why?
Smoking
1
2007
84
0.060
Why?
Gait Disorders, Neurologic
1
2007
67
0.060
Why?
Heart Failure
1
2007
77
0.060
Why?
Apolipoproteins E
2
2022
100
0.060
Why?
Regression Analysis
2
2021
105
0.060
Why?
Cell Count
1
2005
38
0.060
Why?
Causality
2
2020
22
0.060
Why?
Logistic Models
2
2015
196
0.050
Why?
Mice, Knockout
1
2025
170
0.050
Why?
Odds Ratio
2
2017
115
0.050
Why?
Socioeconomic Factors
2
2018
153
0.050
Why?
Phospholipases A2, Cytosolic
1
2022
1
0.050
Why?
Eicosapentaenoic Acid
1
2022
4
0.050
Why?
Arachidonate 5-Lipoxygenase
1
2022
4
0.050
Why?
Epoxide Hydrolases
1
2022
7
0.050
Why?
Kidney Function Tests
1
2002
10
0.050
Why?
Disease Progression
2
2016
290
0.050
Why?
Peptide Fragments
1
2002
27
0.050
Why?
Mice
1
2025
760
0.050
Why?
Reference Values
1
2002
103
0.040
Why?
Parkinson Disease
2
2005
314
0.040
Why?
Supranuclear Palsy, Progressive
1
2001
8
0.040
Why?
Spinocerebellar Degenerations
1
2001
1
0.040
Why?
Tomography, Emission-Computed
1
2001
5
0.040
Why?
Aphasia, Primary Progressive
1
2001
2
0.040
Why?
Fatal Outcome
1
2001
28
0.040
Why?
Arteriosclerosis
1
2021
6
0.040
Why?
Diagnosis, Differential
1
2001
151
0.040
Why?
Genotype
2
2015
169
0.040
Why?
Geriatric Assessment
1
2001
96
0.040
Why?
Obesity
1
2021
156
0.040
Why?
Randomized Controlled Trials as Topic
1
2020
128
0.040
Why?
Calcium
1
2022
288
0.040
Why?
Life Style
1
2020
102
0.040
Why?
AIDS Dementia Complex
1
2000
31
0.040
Why?
Animals
1
2025
2092
0.040
Why?
Tomography, X-Ray Computed
1
2001
281
0.040
Why?
Self Report
1
2020
94
0.040
Why?
Chi-Square Distribution
1
2018
60
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1998
2
0.030
Why?
Meningitis
1
1998
2
0.030
Why?
DNA Fingerprinting
1
1998
4
0.030
Why?
Antitubercular Agents
1
1998
7
0.030
Why?
Canada
1
1998
21
0.030
Why?
Species Specificity
1
1998
28
0.030
Why?
United States
3
2006
989
0.030
Why?
alpha-Synuclein
1
2018
59
0.030
Why?
DNA-Binding Proteins
1
2018
151
0.030
Why?
Likelihood Functions
1
2017
12
0.030
Why?
Hypoglycemic Agents
1
2016
20
0.030
Why?
Arterial Pressure
1
2016
5
0.030
Why?
Genetic Association Studies
1
2015
45
0.030
Why?
Alleles
1
2015
119
0.030
Why?
Healthy Volunteers
1
2015
20
0.030
Why?
Heterozygote
1
2015
72
0.030
Why?
Actigraphy
1
2015
41
0.030
Why?
Time Factors
1
2016
695
0.030
Why?
Epidemiologic Studies
1
2012
14
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2009
5
0.020
Why?
Neocortex
1
2009
17
0.020
Why?
Models, Neurological
1
2009
12
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
47
0.020
Why?
Nerve Degeneration
1
2009
19
0.020
Why?
Enzyme Activation
1
2009
64
0.020
Why?
Up-Regulation
1
2009
89
0.020
Why?
Neurons
1
2009
164
0.020
Why?
Long-Term Care
1
2007
24
0.020
Why?
Ambulatory Care Facilities
1
2006
23
0.020
Why?
Bias
1
2006
16
0.020
Why?
Gene Expression Regulation
1
2007
125
0.010
Why?
Community Health Services
1
2006
19
0.010
Why?
Predictive Value of Tests
1
2006
218
0.010
Why?
Dementia, Vascular
1
2005
19
0.010
Why?
Neurologic Examination
1
2005
49
0.010
Why?
Practice Guidelines as Topic
1
2006
116
0.010
Why?
Practice Patterns, Physicians'
1
2006
68
0.010
Why?
Antihypertensive Agents
1
2005
15
0.010
Why?
Brain Chemistry
1
2005
22
0.010
Why?
Sensitivity and Specificity
1
2006
252
0.010
Why?
Clergy
1
2005
39
0.010
Why?
Proportional Hazards Models
1
2005
161
0.010
Why?
Reproducibility of Results
1
2006
324
0.010
Why?
Analysis of Variance
1
2000
125
0.010
Why?
Arvanitakis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (234)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_